nifedipine has been researched along with ascorbic acid in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.54) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 10 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bharathi, K; Prasad, KV; Prasanthi, G | 1 |
| Bharate, SS; Vishwakarma, RA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Sinitsyn, SP | 1 |
| Engineer, F; Sridhar, R | 1 |
| Beatty, JF; Becker, B; Krupin, T; Nichols, PF | 1 |
| Alov, P; Koleva, M | 1 |
| Fernandes, AC; Filipe, PM; Manso, CF; Silva, JM | 1 |
| Dziewit, T; Jeleń, B; Misiewicz, A; Radwan, K; Srodoń-Sikora, I | 1 |
| Laine, E; Lehto, VP; Salonen, J | 1 |
| Dziewit, T; Jeleń, B; Misiewicz, A; Sieradzka, I; Szota, M | 1 |
| Black, CM; Bruckdorfer, KR; Bunce, TD; Denton, CP; Dorado, MB; Howell, K; Roberts, Z; Wilson, H | 1 |
| Favilla, S; Ghiadoni, L; Magagna, A; Pompella, A; Salvetti, A; Taddei, S; Virdis, A | 1 |
| Baltrusch, HJ; Görlitzer, K | 1 |
| Kuo, SM; Lin, CP; Morehouse, HF | 1 |
| Delogu, MR; Desole, MS; Esposito, G; Miele, E; Miele, M; Migheli, R; Mura, MP; Rocchitta, G; Serra, PA; Taras, MG | 1 |
| Kijne, JW; Memelink, J; Pauw, B; van Duijn, B | 1 |
| Boxberger, S; Graf, EM; Hempel, U; Heubach, JF; Ravens, U; Zahanich, I | 1 |
| Badawy, MM; Gaafa, KM; Hamza, AA | 1 |
| He, Q; Mei, XB; Wang, QQ; Wang, T; Wen, XJ; Xiao, L; Zhang, LM; Zhao, J; Zheng, JM | 1 |
| Cortizo, AM; Fernández, JM; McCarthy, AD; Molinuevo, MS; Schurman, L; Sedlinsky, C | 1 |
1 review(s) available for nifedipine and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for nifedipine and ascorbic acid
| Article | Year |
|---|---|
[Levels of copper, zinc and vitamin C in erythrocytes of humans taking nifedipine].
Topics: Adult; Ascorbic Acid; Copper; Erythrocytes; Humans; Male; Middle Aged; Nifedipine; Zinc | 1998 |
Probucol improves symptoms and reduces lipoprotein oxidation susceptibility in patients with Raynaud's phenomenon.
Topics: Anticholesteremic Agents; Antioxidants; Ascorbic Acid; Cohort Studies; Humans; Lipoproteins; Lipoproteins, LDL; Nifedipine; Oxidation-Reduction; Probucol; Raynaud Disease; Scleroderma, Systemic; Triglycerides; Vasodilator Agents; Vitamin E | 1999 |
23 other study(ies) available for nifedipine and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design, synthesis and evaluation of dialkyl 4-(benzo[d][1,3]dioxol-6-yl)-1,4-dihydro-2,6-dimethyl-1-substituted pyridine-3,5-dicarboxylates as potential anticonvulsants and their molecular properties prediction.
Topics: Absorption; Analgesics; Animals; Anticonvulsants; Antioxidants; Chemistry Techniques, Synthetic; Drug Design; Male; Mice; Pyridines; Rats | 2013 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failure; Ibuprofen; Myocardial Infarction; Myocardium; Nandrolone; Nandrolone Decanoate; Nifedipine; Potassium Magnesium Aspartate; Propranolol; Rabbits; Sodium Oxybate; Vitamin E | 1985 |
Inhibition of rat heart and liver microsomal lipid peroxidation by nifedipine.
Topics: Animals; Ascorbic Acid; Heart; In Vitro Techniques; Lipid Peroxidation; Male; Microsomes; Microsomes, Liver; Myocardium; NADP; Nifedipine; Oxygen Consumption; Proteins; Rats; Rats, Inbred Strains | 1989 |
Elevation of intraocular pressure by calcium channel blockers.
Topics: Administration, Oral; Administration, Topical; Animals; Aqueous Humor; Ascorbic Acid; Calcium Channel Blockers; Diltiazem; Eye; Humans; Intraocular Pressure; Male; Nifedipine; Rabbits; Time Factors; Verapamil | 1984 |
Effect of multiple administration of calcium antagonists on lipid peroxidation in rat liver microsomes.
Topics: Animals; Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Lipid Peroxidation; Male; Microsomes, Liver; Nifedipine; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Verapamil | 1996 |
[Antioxidant effect of drugs used in cardiovascular therapy].
Topics: Adrenergic beta-Antagonists; Antioxidants; Ascorbic Acid; Atenolol; Calcium Channel Blockers; Copper; Female; Fluorescence; Humans; Lipid Peroxidation; Male; Metoprolol; Nifedipine; Pindolol; Propranolol | 1998 |
Real time detection of photoreactivity in pharmaceutical solids and solutions with isothermal microcalorimetry.
Topics: Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Calorimetry; Chemistry, Pharmaceutical; Computer Systems; Evaluation Studies as Topic; Nifedipine; Photochemistry | 1999 |
[Copper, zinc and vitamin C concentrations in polymorphonuclear granulocytes after administration of therapeutic doses of nifedipine in patients with primary hypertension].
Topics: Adult; Ascorbic Acid; Calcium Channel Blockers; Copper; Humans; Hypertension; Male; Middle Aged; Neutrophils; Nifedipine; Zinc | 1998 |
Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Topics: Acetylcholine; Antioxidants; Ascorbic Acid; Blood Pressure; Calcium Channel Blockers; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxidative Stress; Regional Blood Flow; Time Factors; Vasodilation | 2001 |
[Strategies for the synthesis of nifedipine analog esters of l-ascorbic acid].
Topics: Ascorbic Acid; Calcium Channel Blockers; Mass Spectrometry; Nifedipine | 2001 |
Dihydropyridine calcium channel blockers inhibit ascorbic acid accumulation in human intestinal Caco-2 cells.
Topics: Ascorbic Acid; Caco-2 Cells; Calcium Channel Blockers; Diethylstilbestrol; Genistein; Humans; Nicardipine; Nifedipine; Sodium Channels | 2001 |
Role of the nitric oxide/cyclic GMP pathway and ascorbic acid in 3-morpholinosydnonimine (SIN-1)-induced increases in dopamine secretion from PC12 cells. A microdialysis in vitro study.
Topics: Animals; Antioxidants; Ascorbic Acid; Calcium; Calcium Channel Blockers; Cyclic GMP; Dialysis; Dopamine; Drug Interactions; In Vitro Techniques; Molsidomine; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; PC12 Cells; Potassium; Rats; Signal Transduction; Time Factors | 2003 |
Activation of the oxidative burst by yeast elicitor in Catharanthus roseus cells occurs independently of the activation of genes involved in alkaloid biosynthesis.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Ascorbic Acid; Blotting, Northern; Calcium; Catharanthus; Cells, Cultured; Culture Media; Gadolinium; Gene Expression Regulation, Plant; Lanthanum; Models, Biological; Nifedipine; Phosphorylation; Reactive Oxygen Species; RNA, Plant; Secologanin Tryptamine Alkaloids; Yeasts | 2004 |
Molecular and functional expression of voltage-operated calcium channels during osteogenic differentiation of human mesenchymal stem cells.
Topics: Adult; Alkaline Phosphatase; Animals; Ascorbic Acid; Bone Marrow; Bone Marrow Cells; Calcium; Calcium Channels, L-Type; Calcium Channels, T-Type; Carrier Proteins; Cell Differentiation; Cell Line; Culture Media; Dexamethasone; DNA Primers; Flow Cytometry; Glycerophosphates; Glycoproteins; Humans; Membrane Glycoproteins; Mesenchymal Stem Cells; Microscopy, Phase-Contrast; Middle Aged; Nerve Tissue Proteins; Nifedipine; Osteoblasts; Osteopontin; Osteoprotegerin; Patch-Clamp Techniques; Phosphates; Polymerase Chain Reaction; RANK Ligand; Rats; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Sialoglycoproteins | 2005 |
The protective effects of ascorbic acid, cimetidine, and nifedipine on diethyldithiocarbamate-induced hepatic toxicity in albino rats.
Topics: Animals; Ascorbic Acid; Biomarkers; Calcium; Chemical and Drug Induced Liver Injury; Cimetidine; Cytochrome P-450 Enzyme System; Ditiocarb; Dose-Response Relationship, Drug; Glutathione; Lipid Peroxidation; Liver; Male; Malondialdehyde; Nifedipine; Oxidative Stress; Protective Agents; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors | 2011 |
Lipid peroxidation is another potential mechanism besides pore-formation underlying hemolysis of tentacle extract from the jellyfish Cyanea capillata.
Topics: Animals; Antioxidants; Ascorbic Acid; Calcium; Calcium Channel Blockers; Cnidarian Venoms; Diltiazem; Erythrocyte Membrane; Erythrocytes; Glutathione; Hemolysis; Lipid Peroxidation; Male; Malondialdehyde; Nifedipine; Osmosis; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Scyphozoa; Verapamil | 2013 |
Advanced glycation end products and strontium ranelate promote osteogenic differentiation of vascular smooth muscle cells in vitro: Preventive role of vitamin D.
Topics: Animals; Ascorbic Acid; Cell Count; Cell Differentiation; Cell Movement; Core Binding Factor Alpha 1 Subunit; Glycation End Products, Advanced; Male; Models, Biological; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; Osteogenesis; Oxidative Stress; Rats, Sprague-Dawley; Reactive Oxygen Species; Sulfasalazine; Thiophenes; Vitamin D; Vitamin E | 2017 |